A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

The University of Virginia (UVA) is spearheading a nationwide clinical trial exploring a new treatment option for prolonged ...

Ketamine-assisted psychotherapy (KAP) uses low doses of ketamine alongside psychotherapy to treat mental health conditions.

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The study is part of psychiatry’s broad new initiative to normalize the use of hallucinogenic drugs, despite their dangerous ...

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...